CVS Corp
(CVS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,586,000 | 8,196,000 | 12,945,000 | 9,408,000 | 7,854,000 |
| Marketable Securities | 2,407,000 | 3,259,000 | 2,778,000 | 3,117,000 | 3,000,000 |
| Receivables | 36,469,000 | 35,227,000 | 27,276,000 | 24,431,000 | 21,742,000 |
| Inventories | 18,107,000 | 18,025,000 | 19,090,000 | 17,760,000 | 18,496,000 |
| Other current assets | 3,076,000 | 3,151,000 | 3,544,000 | 5,292,000 | 5,277,000 |
| TOTAL | $68,645,000 | $67,858,000 | $65,633,000 | $60,008,000 | $56,369,000 |
| Non-Current Assets | |||||
| PPE Net | 12,993,000 | 13,183,000 | 12,873,000 | 12,896,000 | 12,606,000 |
| Investments And Advances | 28,934,000 | 23,019,000 | 21,096,000 | 23,025,000 | 20,812,000 |
| Intangibles | 118,595,000 | 120,506,000 | 102,953,000 | 108,147,000 | 110,694,000 |
| Other Non-Current Assets | 24,048,000 | 25,162,000 | 25,720,000 | 28,923,000 | 30,234,000 |
| TOTAL | $184,570,000 | $181,870,000 | $162,642,000 | $172,991,000 | $174,346,000 |
| Total Assets | $253,215,000 | $249,728,000 | $228,275,000 | $232,999,000 | $230,715,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 5,743,000 | 2,972,000 | 1,778,000 | 4,205,000 | 5,440,000 |
| Accounts payable and accrued liabilities | 55,122,000 | 49,820,000 | 44,403,000 | 38,682,000 | 34,869,000 |
| Accrued Expenses | 20,810,000 | 23,515,000 | 18,745,000 | 17,670,000 | 14,243,000 |
| Other current liabilities | 1,183,000 | 1,141,000 | 2,817,000 | 5,604,000 | 5,827,000 |
| TOTAL | $84,609,000 | $79,189,000 | $69,421,000 | $67,807,000 | $62,017,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 60,527,000 | 58,638,000 | 50,476,000 | 51,971,000 | 59,207,000 |
| Other Non-Current Liabilities | 28,571,000 | 30,930,000 | 32,577,000 | 31,582,000 | 32,983,000 |
| TOTAL | $92,876,000 | $93,903,000 | $87,085,000 | $89,811,000 | $98,997,000 |
| Total Liabilities | $177,485,000 | $173,092,000 | $156,506,000 | $157,618,000 | $161,014,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,260,795 | 1,258,450 | 1,284,112 | 1,312,510 | 1,311,355 |
| Common Shares | 49,661,000 | 48,992,000 | 48,193,000 | 47,377,000 | 46,513,000 |
| Retained earnings | 62,837,000 | 61,604,000 | 56,398,000 | 54,906,000 | 49,640,000 |
| Other shareholders' equity | 50,000 | -122,000 | -964,000 | 1,271,000 | 1,726,000 |
| TOTAL | $75,730,000 | $76,636,000 | $71,769,000 | $75,381,000 | $69,701,000 |
| Total Liabilities And Equity | $253,215,000 | $249,728,000 | $228,275,000 | $232,999,000 | $230,715,000 |